Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-19-279512
Filing Date
2019-10-31
Accepted
2019-10-31 06:05:06
Documents
14
Period of Report
2019-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d823321d6k.htm 6-K 20809
2 GRAPHIC g823321txs10g1.jpg GRAPHIC 318704
3 GRAPHIC g823321txs11g1.jpg GRAPHIC 190362
4 GRAPHIC g823321txs12g1.jpg GRAPHIC 209182
5 GRAPHIC g823321txs13g1.jpg GRAPHIC 223935
6 GRAPHIC g823321txs14g1.jpg GRAPHIC 274438
7 GRAPHIC g823321txs15g1.jpg GRAPHIC 70732
8 GRAPHIC g823321txs3g1.jpg GRAPHIC 200556
9 GRAPHIC g823321txs4g1.jpg GRAPHIC 317994
10 GRAPHIC g823321txs5g1.jpg GRAPHIC 274277
11 GRAPHIC g823321txs6g1.jpg GRAPHIC 301670
12 GRAPHIC g823321txs7g1.jpg GRAPHIC 258108
13 GRAPHIC g823321txs8g1.jpg GRAPHIC 284737
14 GRAPHIC g823321txs9g1.jpg GRAPHIC 270341
  Complete submission text file 0001193125-19-279512.txt   4423703
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 191181943
SIC: 2834 Pharmaceutical Preparations